Founded in 2019, FUSE-AI GmbH stands for artificial intelligence in radiology. The company develops medical AI software that analyzes MRI images and supports radiologists in diagnosing cancer.

With Prostate.Carcinoma.ai, FUSE-AI has launched a product on the market that offers particular advantages in the detection of prostate cancer:

It delivers high-quality results quickly and efficiently, thus ensuring that the necessary capacity is created in practices.

Prostate.Carcinoma.ai works as a licensed plug-in and can therefore be easily integrated into existing radiology workflows.

Contact:

Margit Frahm
Margit.frahm@fuse-ai.de
0049 40450318-0